Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome

(2013) M. Frimat et al.   BLOOD

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(2013) C.M. Legendre et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab

(2013) Kaan Gulleroglu et al.   PEDIATRIC NEPHROLOGY

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

(2012) J. Zuber et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

(2012) L. T. Roumenina et al.   BLOOD

Carotid Intima-Media Thickness in Children with CKD: Results from the CKiD Study

(2012) T. M. Brady et al.   Clinical Journal of the American Society of Nephrology

The tick-over theory revisited: Is C3 a contact-activated protein?

(2012) Bo Nilsson et al.   IMMUNOBIOLOGY

A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome

(2012) L. Sartz et al.   JOURNAL OF IMMUNOLOGY

Alternative complement pathway assessment in patients with atypical HUS

(2011) Lubka T. Roumenina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance

(2011) Agustín Tortajada et al.   KIDNEY INTERNATIONAL

Cardiovascular complications in children with chronic kidney disease

(2011) Rukshana Shroff et al.   Nature Reviews Nephrology

Atypical hemolytic uremic syndrome

(2011) Chantal Loirat et al.   Orphanet Journal of Rare Diseases

Complement in atherosclerosis: friend or foe?

(2010) W. S. SPEIDL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation

(2010) C. Loirat et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation

(2010) Jean-Claude Davin et al.   PEDIATRIC NEPHROLOGY

DEAP-HUS: Deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome

(2010) Peter F. Zipfel et al.   PEDIATRIC NEPHROLOGY

Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome

(2009) L. T. Roumenina et al.   BLOOD

Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor

(2009) Suzan H M Rooijakkers et al.   NATURE IMMUNOLOGY

A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure

(2009) C. Rinat et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B

(2009) T. Montes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proximal Cerebral Artery Stenosis in a Patient with Hemolytic Uremic Syndrome: Fig 1.

(2008) M.D.I. Vergouwen et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome

(2007) David Kavanagh et al.   MOLECULAR IMMUNOLOGY